典型文献
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer
文献摘要：
Gastric cancer is one of the most common malignant tumors worldwide. China is a large country in which gastric cancer ranks among the top 3 malignant tumors in terms of inci-dence, and related morbidity and mortality1. In the past 20 years, China has made the most outstanding achievements in the diagnosis and treatment of gastric cancer among coun-tries worldwide. The overall 5-year survival rate of patients in China has increased by nearly 10％2. However, early gastric cancer accounts for only 20％ of clinically confirmed cases, the overall effects of therapies for gastric cancer still must be improved3.
文献关键词：
中图分类号：
作者姓名：
Han Liang
作者机构：
Gastric Cancer Center,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
文献出处：
引用格式：
[1]Han Liang-.PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer)[J].癌症生物学与医学（英文版）,2022(05):565-568
A类：
mortality1,improved3
B类：
inhibitors,provide,new,opportunities,conversion,therapy,stage,IV,gastric,cancer,Gastric,one,most,common,malignant,tumors,worldwide,China,large,country,which,ranks,among,top,terms,inci,dence,related,morbidity,In,past,years,has,made,outstanding,achievements,diagnosis,treatment,tries,overall,survival,rate,patients,increased,by,nearly,However,accounts,only,clinically,confirmed,cases,effects,therapies,still,must,be
AB值：
0.604524
相似文献
机标中图分类号，由域田数据科技根据网络公开资料自动分析生成，仅供学习研究参考。
